Selected scientific papers
This section contains a selection of Dr. Breggin's scientific articles spanning 1964 to the present. They can be arranged chronologically in order to facilitate an overview of his work over the years.
 
 

DocumentsDate added

Order by : Name | Date | Hits | [ Ascendant ]
file icon Lobotomies: an alert (1972) 02/01/1972
"Lobotomies: An Alert." (letter) American Journal of Psychiatry 129:98-99, 1972.
file icon Neuropathology and cognitive dysfunction from ECT (1986) 01/01/1986
"Neuropathology and Cognitive Dysfunction from ECT." Psychopharmacology Bulletin 22:476-479, 1986.
file icon Electroshock therapy and brain damage: the acute organic brain syndrome as treatment (1984) 01/01/1984
"Electroshock Therapy and Brain Damage: The Acute Organic Brain Syndrome as Treatment." Behavior and Brain Sciences 7:24-25, 1984.
file icon What cost leukotomy? 01/01/1983
"What Cost Leukotomy?" (letter) American Journal of Psychiatry 140:1101, 1983.
file icon Guidelines for Counseling and Psychotherapy (2008) 02/10/2010
"Practicle Applications: 22 Guidelines for Counseling and Psychotherapy." Ethical Human Psychology and Psychiatry, 10, 43-57, 2008.
file icon Campaigns against racist federal programs by the ICSPP (1995/96) 01/01/1995
"Campaigns against racist federal programs by the Center for the Study of Psychiatry and Psychology." Journal of African American Men 1:No. 3, 3-22. Winter 1995/96.
file icon What pyschologists and psychiatrists need to know about ADHD and stimulants 05/01/2000
"What Psychologists and Psychotherapists Need to Know About ADHD and Stimulants." Changes: An International Journal of Psychology and Psychotherapy, 18:13-23, Spring 2000.
file icon Psychiatric drug-induced Chronic Brain Impairment (CBI) 01/25/2012
Psychiatric drug-induced Chronic Brain Impairment (CBI): Implications for longterm treatment with psychiatric medication. International Journal of Risk & Safety in Medicine, 23: 193-200.
 
Peter R. Breggin, MD
 
Abstract: Understanding the hazards associated with long-term exposure to psychiatric drugs is very important but rarely emphasized in the scientific literature and clinical practice. Drawing on the scientific literature and clinical experience, the author describes the syndrome of Chronic Brain Impairment (CBM) which can be caused by any trauma to the brain including Traumatic Brain Injury (TBI), electroconvulsive therapy (ECT), and long-term exposure to psychiatric medications. Knowledge of the syndrome should enable clinicians to more easily identify long-term adverse effects caused by psychiatric drugs while enabling researchers to approach the problem with a more comprehensive understanding of the common elements of brain injury as they are manifested after long-term exposure to psychiatric medications. Treatment options are also discussed.
file icon From Prozac to Ecstasy: implications of new evidence for drug-induced brain damage (2001) 01/01/2001
"From Prozac to Ecstacy: The Implication of New Evidence for Drug-Induced Brain Damage." Ethical Human Sciences and Services, 3: 3-5, 2001.
file icon Empowering social work in the era of biological psychiatry (2001) 04/01/2001
"Empowering Social Work in the Era of Biological Psychiatry." (2001) [The annual Ephraim Lisansky ecture of the University of Maryland School of Social Work.] Ethical Human Sciences and Services, :197-206.
<< Start < Prev 1 2 3 4 5 6 7 Next > End >>
Results 51 - 60 of 66

 

WARNING!

Most psychiatric drugs can cause withdrawal reactions, sometimes including life-threatening emotional and physical withdrawal problems. In short, it is not only dangerous to start taking psychiatric drugs, it can also be dangerous to stop them. Withdrawal from psychiatric drugs should be done carefully under experienced clinical supervision. Methods for safely withdrawing from psychiatric drugs are discussed in Dr. Breggin's new book, Psychiatric Drug Withdrawal: A Guide for Prescribers, Therapists, Patients, and Their Families.